Shandong Xinhua Pharmaceutical Co Ltd Sustainability Reports

Develops, manufactures, and sells chemical bulk drugs, preparations, and pharmaceutical intermediates, with a focus on antipyretics and analgesics.

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

LEI: 5299003RTCTK7FPHC208

FIGI: BBG001S6SSB9

11 reports from 2017 to 2025

• Shandong Xinhua Pharmaceutical Co Ltd 2025 Annual Report
• Shandong Xinhua Pharmaceutical Co Ltd 2024 Environmental, Social and Governance Report
• Shandong Xinhua Pharmaceutical Co Ltd 2023 Annual Report
• Shandong Xinhua Pharmaceutical Co Ltd 2023 ESG Report
• Shandong Xinhua Pharmaceutical Co Ltd 2022 Environmental, Social and Governance Report